Abstracts Archive - Page 392 of 1683 - ATC Abstracts

2020 American Transplant Congress
Potential Cost-Savings Associated with ANG-3777 for the Treatment of Delayed Graft Function in Kidney Transplantation
M. Cooper¹, T. Mayne², T. Kauf³, M. Gargano³, K. Freemyer³
¹Medstar Georgetown Transplant Institute, Washington, DC, ²Angion Biomedica Corp, San Francisco, CA, ³Genesis Research, Hoboken, NJ
*Purpose: We created a medical cost offset model based upon the results of a Phase 2, double-blind, randomized controlled trial of ANG-3777, a hepatocyte growth…
2020 American Transplant Congress
Sequence Variations of the LMP1 Protein are Detected in Pediatric Transplant Recipients and May Increase the Risk of EBV Disease
B. Mbiribindi¹, M. Arvedson¹, J. Pena¹, O. Hatton², C. Esquivel¹, O. Martinez¹, S. Krams¹
¹Department of Surgery/Division of Abdominal Transplantation, Stanford Univ School of Med, Stanford, CA, ²Molecular Biology, Colorado College, Colorado Springs, CO
*Purpose: Epstein-Barr virus (EBV) infects more than 90% of adults worldwide and is associated with several malignancies, including post-transplant lymphoproliferative disorder (PTLD). PTLD is a…
2020 American Transplant Congress
Association between Ezetimibe Usage and Hepatitis C RNA Levels in Uninfected Kidney Transplant Recipients Who Received Hepatitis C Infected Kidneys
A. Azhar, M. Yazawa, M. Talwar, V. Balaraman, A. Bhalla, U. A. Agbim, B. Maliakkal, J. P. Kothadia, S. Nair, J. D. Eason, M. Z. Molnar
James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN
*Purpose: Our previous data showed that transplantation of kidneys from hepatitis C virus (HCV) infected donors to HCV negative recipients achieved excellent short-term graft function,…
2020 American Transplant Congress
Absolute Lymphocyte Count: Is There a “Safety Corridor?”
G. Elhelou¹, B. Lahr², R. Razonable³
¹Medicine, Division of Infectious Diseases and Global Medicine, University of Florida, Gainesville, FL, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Medicine, Division of Infectious Disease, Mayo Clinic, Rochester, MN
*Purpose: Iatrogenic suppression of T cells is intended to prevent rejection after solid organ transplantation (SOT). This is complicated by opportunistic infections, most notably cytomegalovirus…
2020 American Transplant Congress
The Importance of Annual Medicare Part D Plan Evaluation
L. Potter¹, E. Garrity²
¹Department of Pharmacy, University of Chicago Medicine, Chicago, IL, ²Transplant Institute, University of Chicago Medicine, Chicago, IL
*Purpose: The Medicare open enrollment period is from Oct 15 to Dec 7, annually. The purpose of this project was to objectively measure the benefit…
2020 American Transplant Congress
Increased Transplant Surgery Advanced Practice Provider Involvement Associated with Decreased Hospital Length of Stay and Readmissions Following Kidney Transplantation
E. A. Herriman¹, J. R. Montgomery², K. J. Brown¹, K. J. Woodside¹
¹Surgery-Section of Transplantation, University of Michigan, Ann Arbor, MI, ²Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery Advanced Practice Providers (APPs) are utilized to provide complex care to transplant patients. Daily responsibilities of APPs are broad and variable across…
2020 American Transplant Congress
Lifetime Survival Estimates Following Solid Organ Transplantation in the United States
C. Graham¹, M. Skeans², Y. Ahn², C. Watson³, A. Barlev⁴
¹RTI Health Solutions, Research Triangle Park, NC, ²Chronic Disease Research Group, Minneapolis, MN, ³Atara Biotherapeutics, South San Francisco, CA, ⁴Atara Biotherapeutics, Thousand Oaks, CA
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) contains detailed patient and graft survival data for all solid organ transplants (SOT) in the United States…
2020 American Transplant Congress
The Role and Impact of Transplant Pharmacist Evaluation in a Pre-Kidney Transplant Clinic
B. Valdepenas, D. Choi, J. Benken, M. Campara
Pharmacy Practice and Transplant Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: The Centers for Medicare and Medicaid Services’ interpretative guidelines for conditions of participation for transplant centers define the transplant pharmacist’s role ambiguously. Limited evidence…
2020 American Transplant Congress
PHS High Risk: Is this Classification Still Needed?
L. G. Smith
Vanderbilt Transplant Center, Nashville, TN
*Purpose: The continued shortage of organs for the over 100,000 candidates on the waitlist has led transplant centers to consider organs that have historically higher…
2020 American Transplant Congress
Frequency and Main Diagnoses of Hospitalizations in Patients after Kidney Transplantation
W. Duettmann-Rehnolt, P. Glander, P. Bach, F. Halleck, V. Graf, L. Lehner, M. Duerr, M. Mayrdorfer, K. Budde, M. Naik
Nephrology, Charité-Universitätsmedizin Berlin, Berlin, Germany
*Purpose: Kidney transplant recipients (KTR) suffer many complications and are hospitalized frequently. Specific reasons for hospital admission with detailed information are scarce.*Methods: We retrieved data…